Tikun Olam is the first supplier of medical cannabis in Israel and known worldwide as a pioneer of modern medical cannabis.
Since its establishment in 2006, Tikun Olam has worked with vertical integration – from the plant to the patient. The company cultivates special strains of cannabis and develops medical cannabis products containing fixed and uniform levels of active substances.
For us, Tikun Olam means bringing relief, and our motto is “The patient at the center”. For that purpose we set up the first training clinic of its kind in the world at Tikun Olam House, with a team of qualified and experienced nurses to train and assist patients to achieve the most suitable, effective and safe treatment with unique Tikun Olam products.
We have at our disposal a database built on the experience of treating tens of thousands of patients over the years, containing extensive knowledge about the effects of medical cannabis on various conditions, characterization of strains, dosages, methods of use, and reducing patients’ reliance on conventional medicines.
The indications for treatment with medical cannabis for adults, as instructed by the Ministry of Health MCU, are:
Oncological: A study conducted in collaboration with the Soroka Medical Center and Ben Gurion University found that use of cannabis as an adjunct treatment for cancer patients could be an effective and safe option for helping them to deal with the symptoms of the disease.
- 95.9% reported an improvement in their condition.
- After 6 months of treatment with cannabis, 35.1% reported decreased use of medicines.
- A clear reduction in pain intensity.
- A clear improvement in quality of life.
Gastroenterological: In the first study of its kind in the world, Dr. Naftali and a team of researchers used the Erez strain to treat Crohn’s disease. 45% of patients achieved full remission and 90% reported significant reduction of symptoms, with no significant side effects. There was also a reduction in the use of medication and a clear improvement in appetite and sleeping.
Neurological: A study conducted in collaboration with Sourasky Medical Center in Tel Aviv, in order to assess the possible clinical value of using medical cannabis to treat Tourette’s and the side effects found in regular users, found:
- An improvement in tics
- An improvement in quality of life.
- The average score on the clinical assessment questionnaire was 3.85 out of 5.
Further indications:
- Treatment of pain
- Palliative treatment
- Psychiatric treatment
- Infectious diseases.
For further information on eligibility for a cannabis license click here
